Vitrafy Life Sciences Limited

A$2.45As of Sun 8 Nov 2026, 12:00 UTC
ASX:VFYTechnology
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (46.29%)
Software (Infrastructure)
Beta (5Y) 1.47
PE TTM —
TSR TTM 64.43%
Mkt cap A$186.7M
ROIC (29.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.05
24.37%
(81.89%)
Hold 12|10|2|11|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.03
0.03
0.03
0.04
9.72%
2.69%
5.60%
9.74%
Revenue$M
20.86
21.93
22.45
22.77
4.91%
5.17%
8.46%
9.91%
Peers (US$128.2M)
Cap (US$)
PE
130.0M
—
115.7M
—
128.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.684
(0.088)
(0.086)
EBIT/Intx
1.244
0.180
0.199
Own earn%
(69.86)
(162.44)
(150.82)
Sh yield%
23.70
15.78
15.88
Owners
Insiders/Inst%
2.70
62.30
Short interest%
5.97
SBC / revenue%
5.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
8–12
$1 testx
0.1
Incr. ROIC%
15